Furthermore, our results showed that microbiota composition was associated with ICAM-1, the expression of which contributes to the clinical manifestations of a variety of diseases [71], predominantly by interfering with normal immune function in oncology, cardiovascular, and autoimmune diseases. Here, ICAM1 is linked to autoimmune disease.